Sam Slutsky
Stock Analyst at LifeSci Capital
(2.72)
# 1,856
Out of 5,135 analysts
4
Total ratings
66.67%
Success rate
42.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sam Slutsky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTYX Ventyx Biosciences | Downgrades: Market Perform | $14 | $13.95 | +0.36% | 1 | Jan 8, 2026 | |
| PVLA Palvella Therapeutics | Initiates: Outperform | $90 | $79.92 | +12.61% | 1 | Aug 4, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Outperform | $45 → $101 | $125.63 | -19.61% | 1 | Jul 23, 2025 | |
| IFRX InflaRx | Upgrades: Outperform | n/a | $0.85 | - | 1 | Apr 5, 2023 |
Ventyx Biosciences
Jan 8, 2026
Downgrades: Market Perform
Price Target: $14
Current: $13.95
Upside: +0.36%
Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $79.92
Upside: +12.61%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45 → $101
Current: $125.63
Upside: -19.61%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $0.85
Upside: -